TORONTO, Feb. 1, 2024 /CNW/ - Neighbourly Pharmacy Inc. ("Neighbourly" or the "Company") (TSX: NBLY), Canada's largest and fastest growing network of community pharmacies, will release its financial results for the third quarter of fiscal 2024 prior to the market open on Tuesday, February 13, 2024.
The Company's third quarter earnings release, MD&A and financial statements will be available on the investor relations website at https://investors.neighbourlypharmacy.ca/financials/quarterly-results/default.aspx.
There will be no conference call to discuss the quarter's financial results.
Neighbourly is Canada's largest and fastest growing network of community pharmacies. United by their patient first focus and their role as essential and trusted healthcare hubs within their communities, Neighbourly's pharmacies strive to provide accessible healthcare with a personal touch. Since 2015, Neighbourly has expanded its diversified national footprint to include 294 locations, reinforcing the Company's reputation as the industry's acquirer of choice.
This press release contains forward-looking statements. When used in this news release, the word "will" and similar expressions, as they relate to Neighbourly, are intended to identify forward-looking statements. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Neighbourly as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors, many of which are beyond Neighbourly's control, including, without limitation, the risk factors and other matters set forth in Neighbourly's filings with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada. Neighbourly undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.
February 13, 2024 January 23, 2024 January 15, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load